Benfotiamine - A New Tool In Preventing Diabetic Complications?

Home
>
Diabetes
>
Benfotiamine - A New Tool In Preventing Diabetic Complications?

Benfotiamine - A New Tool In Preventing Diabetic Complications?

Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com

In The News:

Teen learns to tackle Type 2 diabetes
MiamiHerald.com
Mariana is one of scores of teens learning to manage Type 2 diabetes — the most common form of diabetes, affecting 90 to 95 percent of the 26 million Americans with diabetes. With Type 2, the pancreas does not produce enough insulin or the body cannot ...

and more »

Scientist (blog)
Type 1 Diabetes May Be Reversible With Immune Suppressor Protein
Medical News Today
A professor in Melbourne, Australia, who is on a mission to find a cure for type 1 diabetes, believes that the answer, or part of it, lies with an immune suppressor protein called CD52. And if it works for type 1 diabetes, then it may well work for ...
Immune protein could stop diabetes in its tracksScience Daily (press release)
New Guardians Against Diabetes?Scientist (blog)
Immune Protein Acts As 'Braking' Mechanism For Diabetes [VIDEO]Medical Daily
ABC Online -TopNews Arab Emirates
all 6 news articles »

San Francisco Chronicle
Former Patriot happy for shot with Jaguars despite diabetes diagnosis
Florida Times-Union
Yes, a routine blood test and follow-up exam revealed he had Type 2 diabetes. “My mom and dad both have it, so I was bound to get it,” he said. No, the diabetes didn't result in a significant weight loss. “It's not like I lost 30 pounds,” he said. Yes ...
Jaguars give castoffs Deaderick, Love fresh startTbo.com

all 6 news articles »

Diabetes 1.5: The in-between diagnosis
northwestohio.com
TOLEDO -- Diabetes is one of the leading causes of death in Lucas County, and getting proper treatment is essential for a healthy life. Some are diagnosed as insulin-dependent type 1 and some are type 2, but others are in-between, the type 1.5 diabetics.

Fort Worth Star Telegram
Diabetes service dog saves the day and night for Fort Worth teen
Fort Worth Star Telegram
Diagnosed at age 2, his daily routine consists of checking blood sugar levels, counting carbohydrates and getting insulin shots. When Alves was 6, his father died of the disease at age 36. Unlike Type 2 diabetes, fueled by obesity and inactivity, Type ...

Defeating diabetes: Scholarships to help local student reach goal
Yuma Sun
Yuma High School student Josh Owl, 18, recently received a number of scholarships that will help him pay for his tuition at the University of Arizona, where he hopes to use his education to ultimately become a biomedical engineer and help eradicate ...

Local Guyanese battle diabetes
Albany Times Union
Beyond the city, it is contributing to an evolving understanding of how race and ethnicity play a role in one's chances of developing diabetes and in defining a healthy weight, said Dr. Utpal Pajvani of Columbia University's Naomi Berrie Diabetes ...

David Sedaris: Let's Explore Diabetes with Owls
WNYC
David Sedaris, a master of the personal essay, talks about writing about his family, living abroad, and keeping a diary. He's a regular contributor to The New Yorker, This American Life, and BBC Radio 4, and his latest book is Let's Explore Diabetes ...

Rhythm Pharmaceuticals-funded study says gastroparesis common with Type 2 ...
Boston Business Journal (blog)
The Boston-based biotech company, which specializes in treatments for metabolic diseases including obesity and diabetes, made both announcements Monday from the Digestive Disease Week 2013 conference in Orlando, Fla. The epidemiology study was ...
Rhythm Announces Study Demonstrating High Prevalence of Diabetic ...PR Newswire (press release)
Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for ...MarketWatch (press release)

all 3 news articles »

Police cite man touting 'diabetes solutions'
KPHO Phoenix
Those are exactly the words you'd want to hear if you've been living with Type 2 diabetes for the past five years, like Barker. He and his wife attended one of Babcock's "diabetes solutions" seminars, along with about 120 other people, at the Hilton in ...

and more »

Google News

Benfotiamine - A New Tool In Preventing Diabetic Complications?

Diabetes Diabetes